{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T12:09:09Z","timestamp":1768478949002,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T00:00:00Z","timestamp":1492560000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s10354-017-0557-3","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T12:45:20Z","timestamp":1492605920000},"page":"160-168","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Modulation of gastrointestinal motility beyond metoclopramide and domperidone","Modulation der gastrointestinalen Motilit\u00e4t jenseits von Metoclopramid und Domperidon"],"prefix":"10.1007","volume":"167","author":[{"given":"Ahmed","family":"Madisch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina R.","family":"Vinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Kelber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Nieber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Storr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,19]]},"reference":[{"issue":"11","key":"557_CR1","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1111\/j.1572-0241.2003.07699.x","volume":"98","author":"NJ Talley","year":"2003","unstructured":"Talley NJ, Dennis EH, Schettler-Duncan VA, et al. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol. 2003;98(11):2454\u20139.","journal-title":"Am. J. Gastroenterol."},{"key":"557_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.phymed.2006.03.016","volume":"13","author":"U Kroll","year":"2006","unstructured":"Kroll U, Cordes C. Pharmaceutical prerequisites for a\u00a0multi-target therapy. Phytomedicine. 2006;13:12\u20139.","journal-title":"Phytomedicine"},{"issue":"4","key":"557_CR3","first-page":"1","volume":"2","author":"K Nicolay","year":"1984","unstructured":"Nicolay K. Funktionelle Gastroenteropathien im therapeutischen Blindvergleich von Metoclopramid mit dem Phytopharmakon Iberogast (Functional gastroenteropathies in therapeutic blind comparison of metoclopramide with the phytopharmaceutical Iberogast). Gastro Entero Hepatol. 1984;2(4):1\u201312.","journal-title":"Gastro Entero Hepatol"},{"issue":"10","key":"557_CR4","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1055\/s-2007-963357","volume":"45","author":"R Raedsch","year":"2007","unstructured":"Raedsch R, Hanisch J, Bock P, et\u00a0al. Wirksamkeit und Unbedenklichkeit des Phytopharmakons STW 5 versus Metoclopramid bei funktioneller Dyspepsie unter Praxisbedingungen \u2013 eine retrolektive Kohortenstudie. [Assessment of the efficacy and safety of the phytopharmacon STW 5 versus metoclopramide in functional dyspepsia \u2013 a retrolective cohort study. Z\u00a0Gastroenterol. 2007;45(10):1041\u20138.","journal-title":"Z Gastroenterol"},{"key":"557_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1365-2036.2005.02572.x","volume":"22","author":"B Adam","year":"2005","unstructured":"Adam B, Liebregts T, Saadat-Gilani K, et al. Validation of the gastrointestinal symptom score for the assessment of symptoms in patients with functional dyspepsia. Aliment Pharmacol Ther. 2005;22:357\u201363.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"557_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1055\/s-2002-32130","volume":"40","author":"W R\u00f6sch","year":"2002","unstructured":"R\u00f6sch W, Vinson B, Sassin I. A randomised clinical trial comparing the efficacy of a\u00a0herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia. Z\u00a0Gastroenterol. 2002;40(6):401\u20138.","journal-title":"Z Gastroenterol"},{"issue":"1","key":"557_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3109\/00365529409090434","volume":"29","author":"I Fumagalli","year":"1994","unstructured":"Fumagalli I, Hammer B. Cisapride versus metoclopramide in the treatment of functional dyspepsia. A double-blind comparative trial. Scand J Gastroenterol. 1994;29(1):33\u20137.","journal-title":"Scand. J. Gastroenterol."},{"issue":"3","key":"557_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1365-2036.2004.01859.x","volume":"19","author":"A Madisch","year":"2004","unstructured":"Madisch A, Holtmann G, Plein K, et al. Treatment of irritable bowel syndrome with herbal preparations: results of a\u00a0double-blind, randomized, placebo-controlled, multi-centre trial. Aliment Pharmacol Ther. 2004;19(3):271\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"557_CR9","volume-title":"Post - marketing surveillance of the efficacy and tolerability of Iberogast for the therapy of colon irritabile","author":"C Klein-Galczinsky","year":"1999","unstructured":"Klein-Galczinsky C, Sassin I. Post - marketing surveillance of the efficacy and tolerability of Iberogast for the therapy of colon irritabile. 10th Annual Meeting of the German Society for Phytotherapy, M\u00fcnster. 1999."},{"issue":"3\u20134","key":"557_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10354-012-0169-x","volume":"163","author":"B Ottillinger","year":"2013","unstructured":"Ottillinger B, Storr M, Malfertheiner P, et\u00a0al. STW 5 (Iberogast\u00ae) \u2013 a safe and effective standard in the treatment of functional gastrointestinal disorders. Wien Med Wochenschr. 2013;163(3\u20134):65\u201372.","journal-title":"Wien Med Wochenschr"},{"key":"557_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1055\/s-0030-1247642","volume":"31","author":"O Kelber","year":"2010","unstructured":"Kelber O. Anwendungsbeobachtungen und retrospektive Studien bei Kindern. Z\u00a0Phytother. 2010;31:40\u20137.","journal-title":"Z Phytother"},{"key":"557_CR12","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1055\/s-0029-1241424","volume":"47","author":"B Vinson","year":"2009","unstructured":"Vinson B, Radke M. Das pflanzliche Therapeutikum STW 5 zur Behandlung von funktionellen gastrointsetinalen Erkrankungen bei Kindern von 3\u201314\u00a0Jahren \u2013 eine prospektive nicht interventionelle Studie. Z\u00a0Gastroenterol. 2009;47:917.","journal-title":"Z Gastroenterol"},{"issue":"4","key":"557_CR13","first-page":"356","volume":"4","author":"M Storr","year":"2016","unstructured":"Storr M, Ottillinger B, Allescher H\u2011D, et al. STW 5 (Iberogast) bei funktionellen gastrointestinalen Erkrankungen. Pharmakon. 2016;4(4):356\u201364.","journal-title":"Pharmakon"},{"issue":"2","key":"557_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0014-2999(85)90714-9","volume":"108","author":"MW Lobbezoo","year":"1985","unstructured":"Lobbezoo MW, Janszen FH, Tulp MT, et\u00a0al. Differential effects of metoclopramide and zetidoline on gastrointestinal motility. Eur J Pharmacol. 1985;108(2):105\u201312.","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"557_CR15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/00005176-198601000-00025","volume":"5","author":"C Hillemeier","year":"1986","unstructured":"Hillemeier C, McCallum R, Oertel R, et\u00a0al. Effect of bethanechol and metoclopramide on upper gastrointestinal motility in the kitten. J\u00a0Pediatr Gastroenterol Nutr. 1986;5(1):134\u20137.","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"6","key":"557_CR16","first-page":"631","volume":"41","author":"AA Megens","year":"1991","unstructured":"Megens AA, Awouters FH, Niemegeers CJ. General pharmacology of the four gastrointestinal motility stimulants bethanechol, metoclopramide, trimebutine, and cisapride. Arzneimittelforschung. 1991;41(6):631\u20134.","journal-title":"Arzneimittelforschung"},{"key":"557_CR17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.coph.2011.09.007","volume":"11","author":"SM Brierley","year":"2011","unstructured":"Brierley SM, Kelber O. Use of natural products in gastrointestinal therapies. Curr Opin Pharmacol. 2011;11:604\u201311.","journal-title":"Curr Opin Pharmacol"},{"key":"557_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.phymed.2006.08.004","volume":"13","author":"HPT Ammon","year":"2006","unstructured":"Ammon HPT, Kelber O, Okpanyi SN. Spasmolytic and tonic effect of Iberogast (STW 5) in intstinal smooth muscle. Phytomedicine. 2006;13:67\u201374.","journal-title":"Phytomedicine"},{"key":"557_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.phymed.2006.03.013","volume":"13","author":"H Heinle","year":"2006","unstructured":"Heinle H, Hagelauer D, Pascht U, et\u00a0al. Intestinal spasmolytic effects of STW 5 (Iberogast) and its components. Phytomedicine. 2006;13:75\u20139.","journal-title":"Phytomedicine"},{"issue":"1","key":"557_CR20","first-page":"31","volume":"34","author":"J Kelm","year":"2013","unstructured":"Kelm J, Feierabend M, Merkel K, et al. Peroxide-induced effects on spontaneous contraction of murine small intestine: lack of inhibition by antioxidants. Z\u00a0Phytother. 2013;34(1):31.","journal-title":"Z Phytother"},{"key":"557_CR21","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1055\/s-0028-1089729","volume":"46","author":"M Schemann","year":"2008","unstructured":"Schemann M, Angay O, Wagner S, et\u00a0al. Wirkung von STW 5 auf die Motilit\u00e4t des unteren Oesophagussphinkters und des Kolons: neue Indikationen f\u00fcr Iberogast. Z\u00a0Gastroenterol. 2008;46:1039.","journal-title":"Z Gastroenterol"},{"issue":"2\u20133","key":"557_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.phymed.2008.10.011","volume":"16","author":"S Michael","year":"2009","unstructured":"Michael S, Kelber O, Hauschildt S, et al. Inhibition of inflammation-induced alterations in rat small intestine by the herbal preparations STW 5 and STW 6. Phytomedicine. 2009;16(2\u20133):161\u201371.","journal-title":"Phytomedicine"},{"key":"557_CR23","first-page":"931","volume":"51","author":"A Sibaev","year":"2013","unstructured":"Sibaev A, Abdel-Aziz H, Kelber O, et al. Antiinflammatorische Wirkung von STW 5 (Iberogast) und seinen Einzelextrakten auf die durch Entz\u00fcndungsvorg\u00e4nge ver\u00e4nderte Motilit\u00e4t in vitro. Z\u00a0Gastroenterol. 2013;51:931.","journal-title":"Z Gastroenterol"},{"issue":"11","key":"557_CR24","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00384-012-1473-z","volume":"27","author":"W Wadie","year":"2012","unstructured":"Wadie W, Abdel-Aziz H, Zaki HF, et al. STW 5 is effective in dextran sulfate sodium-induced colitis in rats. Int J Colorectal Dis. 2012;27(11):1445\u201353.","journal-title":"Int J Colorectal Dis"},{"key":"557_CR25","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.phymed.2006.03.020","volume":"13","author":"M Schemann","year":"2006","unstructured":"Schemann M, Michel K, Zeller F, et al. Region-specific effects of STW 5 (Iberogast) and its components in gastric fundus, corpus and antrum. Phytomedicine. 2006;13:90\u20139.","journal-title":"Phytomedicine"},{"key":"557_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1572-0241.2007.01142.x","volume":"102","author":"AN Pilichiewicz","year":"2007","unstructured":"Pilichiewicz AN, Horowitz M, Russo A, et\u00a0al. Effects of Iberogast on Proximal gastric volume, antropyloroduodenal motility and gastric emptying in healthy men. Am J Gastroenterol. 2007;102:1\u20138.","journal-title":"Am. J. Gastroenterol."},{"key":"557_CR27","doi-asserted-by":"publisher","first-page":"KG198","DOI":"10.1055\/s-0034-1386222","volume":"52","author":"S Hoser","year":"2014","unstructured":"Hoser S, Kelber O, Abdel-Aziz H, et al. Kooperativit\u00e4t von Bestandteilen des Phytopharmakons STW 5 auf entz\u00fcndliche Prozesse am Darm. Z\u00a0Gastroenterol. 2014;52:KG198, DGVS Leipzig.","journal-title":"Z Gastroenterol"},{"key":"557_CR28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.phymed.2006.03.022","volume":"13","author":"W R\u00f6sch","year":"2006","unstructured":"R\u00f6sch W, Liebregts T, Gundermann KJ, et\u00a0al. Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5. Phytomedicine. 2006;13:114\u201321.","journal-title":"Phytomedicine"},{"key":"557_CR29","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/j.1365-2036.2004.02275.x","volume":"20","author":"J Melzer","year":"2004","unstructured":"Melzer J, R\u00f6sch W, Reichling J, et al. Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast). Aliment Pharmacol Ther. 2004;20:1279\u201387.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"557_CR30","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1254\/jphs.09355FP","volume":"113","author":"H Abdel-Aziz","year":"2010","unstructured":"Abdel-Aziz H, Zaki HF, Neuhuber W, et al. Effect of an herbal preparation, STW 5, in an acute model of reflux oesophagitis in rats. J Pharmacol Sci. 2010;113(2):134\u201342.","journal-title":"J. Pharmacol. Sci."},{"issue":"11","key":"557_CR31","first-page":"925","volume":"49","author":"A Madisch","year":"1999","unstructured":"Madisch A, Heydenreich C, Wieland V, et al. Treatment of functional dyspepsia with a\u00a0fixed peppermint oil and caraway oil combination preparation as compared to cisapride. A multicenter, reference-controlled double-blind equivalence study. Arzneimittelforschung. 1999;49(11):925\u201332.","journal-title":"Arzneimittelforschung"},{"issue":"113","key":"557_CR32","first-page":"62","volume":"59","author":"M Arai","year":"2012","unstructured":"Arai M, Matsumura T, Tsuchiya N, et\u00a0al. Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin. Hepatogastroenterology. 2012;59(113):62\u20136.","journal-title":"Hepatogastroenterology"},{"issue":"5","key":"557_CR33","first-page":"454","volume":"28","author":"LY Xia","year":"2008","unstructured":"Xia LY, Ge WJ, Liu WJ. Therapeutic effect of hewei xiaopi capsule for treatment of dyskinesis functional dyspepsia. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008;28(5):454\u20136.","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"issue":"1","key":"557_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/BF02835744","volume":"11","author":"SP Yu","year":"2005","unstructured":"Yu SP, Ye H, Ha NL, et\u00a0al. Effect of modified Sinisan on anorectal manometry of the constipation predominant type of irritable bowel syndrome. Chin J Integr Med. 2005;11(1):27\u201330.","journal-title":"Chin J Integr Med"},{"issue":"1","key":"557_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D, et\u00a0al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials. 1996;17(1):1\u201312.","journal-title":"Control Clin Trials"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-017-0557-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-017-0557-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-017-0557-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T14:13:48Z","timestamp":1493388828000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-017-0557-3"}},"subtitle":["Pharmacological and clinical evidence for phytotherapy in functional gastrointestinal disorders","Pharmakologische und klinische Evidenz f\u00fcr die Phytotherapie bei funktionellen Magen-Darm-Erkrankungen"],"short-title":[],"issued":{"date-parts":[[2017,4,19]]},"references-count":35,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["557"],"URL":"https:\/\/doi.org\/10.1007\/s10354-017-0557-3","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,19]]}}}